United States · FDA National Drug Code directory
LANSOPRAZOLE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70771-1132_05217d4a-ad65-460c-b041-e17fda6eec59
- Product NDC
- 70771-1132
- Form
- TABLET, ORALLY DISINTEGRATING
- Composition / generic term
- LANSOPRAZOLE
- Labeler
- Zydus Lifesciences Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20181130
- Source listing expiry
- 20261231
Source-listed ingredients
- LANSOPRAZOLE — 15 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 10 BLISTER PACK in 1 CARTON (70771-1132-4) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK · 70771-1132-4
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →